Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease

INTRODUCTION: People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS. METHODS: Noradrenaline, adrenaline, and their metabolite 3-methoxy-4-hydroxyphen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Dekker, Alain D., Vermeiren, Yannick, Carmona-Iragui, Maria, Benejam, Bessy, Videla, Laura, Gelpi, Ellen, Aerts, Tony, Van Dam, Debby, Fernández, Susana, Lleó, Alberto, Videla, Sebastian, Sieben, Anne, Martin, Jean-Jacques, Blesa, Rafael, Fortea, Juan, De Deyn, Peter P.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
CSF Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956808/
https://ncbi.nlm.nih.gov/pubmed/29780859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.11.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados